Zobrazeno 1 - 10
of 587
pro vyhledávání: '"Peter C Black"'
Autor:
Gary D Steinberg, Neal Shore, Petros Grivas, Matthew D Galsky, Elizabeth R Plimack, Shilpa Gupta, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Jonathan E Rosenberg, Ashish M Kamat
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis). For these immunotherapies to positively impact patient outcomes, optimal sel
Externí odkaz:
https://doaj.org/article/977912e59a574bb1b59459f6b2d76b99
Autor:
Maryam Asadi-Aghbolaghi, Amirali Darbandsari, Allen Zhang, Alberto Contreras-Sanz, Jeffrey Boschman, Pouya Ahmadvand, Martin Köbel, David Farnell, David G. Huntsman, Andrew Churg, Peter C. Black, Gang Wang, C. Blake Gilks, Hossein Farahani, Ali Bashashati
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-18 (2024)
Abstract Investigation of histopathology slides by pathologists is an indispensable component of the routine diagnosis of cancer. Artificial intelligence (AI) has the potential to enhance diagnostic accuracy, improve efficiency, and patient outcomes
Externí odkaz:
https://doaj.org/article/72c28cf50b92406fb499cf977e8ae969
Autor:
Tessa Ladner, Anna J. Black, Homayoun Zargar, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Michael S. Cookson, Niels-Erik Jacobsen, Adrian S. Fairey, Colin P. N. Dinney, Maria C. Mir, Laura-Maria Krabbe, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Andrew J. Stephenson, Jay B. Shah, Siamak Daneshmand, Kamran Zargar-Shoshtari, Philippe E. Spiess, Laura S. Mertens, Bas W. G. van Rhijn, Petros Grivas, Wassim Kassouf, Marc A. Dall’Era, Srikala S. Sridhar, Jonathan S. McGrath, Jonathan Aning, Shahrokh F. Shariat, Trinity J. Bivalacqua, Scott A. North, Daniel A. Barocas, Yair Lotan, Peter C. Black
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 3, Pp 202-213 (2024)
Objectives: Perioperative blood transfusion (PBT) has been associated with worse survival after radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC). Here, we evaluated the association between PBT and survival after RC that
Externí odkaz:
https://doaj.org/article/014c07b617934d568005c539c0294ffb
Autor:
Nilanga Aki Bandara, Xuan Randy Zhou, Abdullah Alhamam, Peter C. Black, Marie-Pier St-Laurent
Publikováno v:
Société Internationale d’Urologie Journal, Vol 5, Iss 2, Pp 97-100 (2024)
Electronic cigarette use is rising globally. Although it may represent a potential smoking cessation tool, amidst misinformation and social media promotion, there is a growing concern regarding the health risks associated with its usage. These risks
Externí odkaz:
https://doaj.org/article/a1505c059057464f877774d96a147e05
Autor:
Rui M. Gil da Costa, Christine Levesque, Daniella Bianchi‐Frias, Payel Chatterjee, Hung‐Ming Lam, Carlos Santos, Ilsa M. Coleman, Pedro Ferreirinha, Manuel Vilanova, Nazaré Pinto da Cunha, Hugo Carvalho, Alexandra Moreira‐Pais, Ana Faustino‐Rocha, Tiago Neto, José Batista da Costa, Jonathan L. Wright, Rita Ferreira, Paula A. Oliveira, Joaquim Mendes, Margarida M. S. M. Bastos, Bruno Colaço, Carlos Lopes, Peter C. Black, Christopher J. Sweeney, Peter S. Nelson
Publikováno v:
Molecular Oncology, Vol 17, Iss 12, Pp 2709-2727 (2023)
Most patients with muscle‐invasive bladder cancer (MIBC) are not cured with platinum chemotherapy. Up‐regulation of nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) is a major mechanism underlying chemoresistance, sugge
Externí odkaz:
https://doaj.org/article/c67189174a934005bc879e99ac388170
Autor:
Sunyoung Park, Richard R Ang, Simon P Duffy, Jenny Bazov, Kim N Chi, Peter C Black, Hongshen Ma
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85264 (2014)
Circulating tumor cell (CTC) enumeration promises to be an important predictor of clinical outcome for a range of cancers. Established CTC enumeration methods primarily rely on affinity capture of cell surface antigens, and have been criticized for u
Externí odkaz:
https://doaj.org/article/6ffab34748994996b4434dfefa63c070
Autor:
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, Anirban P Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J Bergstralh, Thomas Kollmeyer, Stephanie Fink, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Karla V Ballman, Timothy J Triche, Peter C Black, R Jeffrey Karnes, George Klee, Elai Davicioni, Robert B Jenkins
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66855 (2013)
Clinicopathologic features and biochemical recurrence are sensitive, but not specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a genomic expression signature detected in the primary tumor represents true biolo
Externí odkaz:
https://doaj.org/article/880a5c46174d490ab5024790b6997a2b
Autor:
Wolfgang Jäger, Igor Moskalev, Claudia Janssen, Tetsutaro Hayashi, Shannon Awrey, Kilian M Gust, Alan I So, Kaixin Zhang, Ladan Fazli, Estelle Li, Joachim W Thüroff, Dirk Lange, Peter C Black
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e59536 (2013)
Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall
Externí odkaz:
https://doaj.org/article/ebcb698bc91941febf61917be534a7b3
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57284 (2013)
Fibroblast growth factor receptors (FGFRs) are activated by mutation and overexpressed in bladder cancers (BCs), and FGFR inhibitors are currently being evaluated in clinical trials in BC patients. However, BC cells display marked heterogeneity in th
Externí odkaz:
https://doaj.org/article/d14498d357694471a910ddac86d2ebf5
Autor:
Tima Mohammadi, Daphne P. Guh, Alexander C. T. Tam, Reka E. Pataky, Peter C. Black, Alan So, Larry D. Lynd, Wei Zhang, Annalijn I. Conklin
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 20106-20118 (2023)
Abstract Background The current prostate cancer (PCa) screening standard of care (SOC) leads to unnecessary biopsies and overtreatment because decisions are guided by prostate‐specific antigen (PSA) levels, which have low specificity in the gray zo
Externí odkaz:
https://doaj.org/article/bd5f644f8317435f92ef192245ad77ec